EG ·
angiosartan 10 mg 21 tablet
angiosartan 10 mg 21 tablet
Composition
These source-reported data require scientific review and are not treatment advice.
OLMESARTAN
· AMOUNT_PER_UNIT
OLMESARTAN
· AMOUNT_PER_UNIT
Registration
Packages and prices
ANGIOSARTAN 10 MG 21 TABLET
Explainable alternatives
Candidates are informational and are not automatic authorization for substitution or dispensing.
| Product | Match | Differences | Price |
|---|---|---|---|
| angiosartan 40 mg 21 tab | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| Angiosartan 40 mg 14 tab | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| angiosartan 10 mg 28 tab | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| NORMESAR 40MG 30 TAB | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| angiosartan 20 mg 28 tab | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| angiosartan 20 mg 14 tab | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| Angiosartan 10mg 14tab | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| MARVITENSE 40 5 12.5MG 30 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |
| OLMESAB 40 MG 20 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |
| angiosartan plus 40/25 28 tab | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |
| OLMESPIRONOVA 20/12.5 MG 30 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis | — EGP |
| MARVITENSE 20 5 12.5MG 30 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |